← Insider buys
SYRS

Syros Pharmaceuticals, Inc. · Healthcare

Chief Business Officer Jeremy P. Springhorn bought $136K of Syros Pharmaceuticals, Inc.

Bought$136,260
$9.08Price
15,000Shares

What SYRS did for a copier

Prices for SYRS after this filing aren't in yet.

Jeremy P. Springhorn's record

1 other buy on record. A record shows here once 3 of them have 3 months of prices.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Fri, Dec 15. Filed Fri, Dec 15, 11:02 AM ET, during the session. Not investment advice.